Skip to content

Navauppu mezhugu for Rheumatoid arthritis

Clinical evalution of nava uppu mezhugu internal medicine and vatha kesari thylam external medicine in the management of uthira vatha suronitham rheumatoid arthritis - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066620
Enrollment
35
Registered
2024-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Navauppu mezhugu: Navauppu mezhugu is a siddha herbo mineral formulation which used to treatment of arthritis vascular disease and anemia .It is given with palm jaggery Control Inter

Sponsors

Ayothidoss pandithar hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults with rheumatoid arthritis based on EULAR ACR score greater than 6 by10 Patients with moderate DAS score 3 point 2 to 5 point 1 Patients who are willing to attend OPD or willing for admission in IPD Patients who are willing to undergo Radiological investigation and other laboratory investigation Patient who are willing to sign the informed consent stating that he she will consciously stick to the treatment during 75 days but can stop opt out of the trail of his her own conscious discretion

Exclusion criteria

Exclusion criteria: Pregnancy and lactating mother Hypothyroidism and hyperthyroidism Uncontrolled Hypertension greater than 180 by 110 mm Hg Liver disease Neurological disease Recent treatment with steroids before 3 months Uncontrolled Diabetes mellitus HbA1c greater than 8 point 2 percentage Known case of Any other arthritis History of trauma Extra articular involvement of Rheumatoid arthritis except anemia

Design outcomes

Primary

MeasureTime frame
The primary outcome will be Reduction of pain and swelling of the joints, Improvement in the movement of affected joints, and Reduction of disability DAS SCALETimepoint: 4 months screening 2 months recruiting 2 month data collection 6 month treatment period 4 month data analysis

Secondary

MeasureTime frame
Improvement in the quality of life Qualisex questionnaire Anti inflammatory effect of vadha kesari thylam will be assessed by in vitro Cox inhibition assayTimepoint: 2 months for lab work 2 months for data analysi

Countries

India

Contacts

Public ContactDr T Lakshmikantham

National Institute of Siddha

drlakshmiramaswamy@gmail.com9025575185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026